Filtern
Erscheinungsjahr
- 2022 (2)
Dokumenttyp
Sprache
- Englisch (2)
Referierte Publikation
- ja (2)
Schlagworte
- Ab initio (1)
- Anticancer (1)
- Carbide (1)
- Clerodin (1)
- Complexity (1)
- High-strength steel (1)
- Hydrogen (1)
Organisationseinheit der BAM
The microstructure of advanced high-strength steels often shows a sensitive dependence on alloying. For example, adding Cr to improve the corrosion resistance of medium-Mn steels also enhances the precipitation of carbides. The current study focuses on the behavior of H in such complex multicomponent carbides by employing different methodological strategies. We systematically analyze the impact of Cr, Mn, and Fe using density functional theory (DFT) for two prototype precipitate phases, M3C and M23C6, where M represents the metal sublattice. Our results show that the addition of these alloying elements yields strong nonmonotonic chemical trends for the H solubility. We identify magnetovolume effects as the origin for this behavior, which depend on the considered system, the sites occupied by H, and short- vs long-range interactions between H and the alloying elements. We further show that the H solubility is directly correlated with the occupation of its nearest-neighbor shells by Cr and Mn. Based on these insights, DFT data from H containing binary-metal carbides are used to design a ridge regression based model that predicts the solubility of H in the ternary-metal carbides (Fe-Cr-Mn-C).
Clerodin was isolated from the medicinal plant Clerodendrum infortunatum, and CSD search showed the first crystal structure of clerodin by a single-crystal X-ray diffraction study. We checked its binding potential with target proteins by docking and conducted network pharmacology analysis, ADMET analysis, in silico pathway analysis, normal mode analysis (NMA), and cytotoxic activity studies to evaluate clerodin as a potential anticancer agent. The cell viability studies of clerodin on the human breast carcinoma cell line (MCF-7) showed toxicity on MCF-7 cells but no toxicity toward normal human lymphocyte cells (HLCs). The anticancer mechanism of clerodin was validated by its enhanced capacity to produce intracellular reactive oxygen species (ROS) and to lower the reduced glutathione content in MCF-7 cells.